{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:54:50Z","timestamp":1764831290733,"version":"3.46.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00210-025-04340-3","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:28:57Z","timestamp":1749169737000},"page":"17211-17224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting inflammatory dysregulation in metabolic dysfunction-associated steatotic liver disease rat model: the preventive and therapeutic effects of acetyl-11-keto-beta-boswellic acid"],"prefix":"10.1007","volume":"398","author":[{"given":"Sajad","family":"Ehtiati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roya","family":"Pakrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed Hossein","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza Ataei","family":"Kachouei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Doagoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Lanjanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed Amir Hossein","family":"Ghazizadeh Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhane","family":"Ahmadzade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Salmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Karima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"6","key":"4340_CR1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","volume":"42","author":"IS Afonina","year":"2015","unstructured":"Afonina IS, M\u00fcller C, Martin SJ, Beyaert R (2015) Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 42(6):991\u20131004","journal-title":"Immunity"},{"issue":"1","key":"4340_CR2","doi-asserted-by":"publisher","first-page":"e000650","DOI":"10.1136\/bmjdrc-2019-000650","volume":"7","author":"T Almog","year":"2019","unstructured":"Almog T, Kandel Kfir M, Levkovich H, Shlomai G, Barshack I, Stienstra R et al (2019) Interleukin-1\u03b1 deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice. BMJ Open Diabetes Res Care 7(1):e000650","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"7","key":"4340_CR3","first-page":"1660","volume":"15","author":"JZ AlTamimi","year":"2023","unstructured":"AlTamimi JZ, AlFaris NA, Alshammari GM, Alagal RI, Aljabryn DH, Yahya MA (2023) The protective effect of 11-keto-\u03b2-boswellic acid against diabetic cardiomyopathy in rats entails activation of AMPK. Nutr 15(7):1660","journal-title":"Nutr"},{"issue":"11","key":"4340_CR4","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.3390\/ijms21114189","volume":"21","author":"T Auguet","year":"2020","unstructured":"Auguet T, Bertran L, Binetti J, Aguilar C, Mart\u00ednez S, Sabench F et al (2020) Relationship between IL-8 circulating levels and TLR2 hepatic expression in women with morbid obesity and nonalcoholic steatohepatitis. Int J Mol Sci 21(11):4189","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4340_CR5","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3390\/jcm13113132","volume":"13","author":"H Bader","year":"2024","unstructured":"Bader H, Yamin S, Alshahwan H, Farraj H, Maghnam J, Omar YA (2024) Association between metabolic-dysfunction-associated steatotic liver disease and hepatic cancer: current concepts and future challenges. J Clin Med 13(11):3132","journal-title":"J Clin Med"},{"issue":"18","key":"4340_CR6","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.3748\/wjg.v30.i18.2387","volume":"30","author":"A Boldys","year":"2024","unstructured":"Boldys A, Buldak L (2024) Metabolic dysfunction-associated steatotic liver disease: navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration. World J Gastroenterol 30(18):2387","journal-title":"World J Gastroenterol"},{"issue":"D1","key":"4340_CR7","doi-asserted-by":"publisher","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","volume":"49","author":"SK Burley","year":"2021","unstructured":"Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow GV et al (2021) RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res 49(D1):D437\u2013D451","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4340_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.gendis.2021.12.006","volume":"10","author":"HV Charan","year":"2023","unstructured":"Charan HV, Dwivedi DK, Khan S, Jena G (2023) Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: therapeutic potential for liver fibrosis. Genes Dis 10(2):480\u2013494","journal-title":"Genes Dis"},{"key":"4340_CR9","doi-asserted-by":"publisher","first-page":"111341","DOI":"10.1016\/j.intimp.2023.111341","volume":"127","author":"Y Chen","year":"2024","unstructured":"Chen Y, Huang Y, Huang R, Chen Z, Wang X, Chen F, Huang Y (2024) Interleukin-10 gene intervention ameliorates liver fibrosis by enhancing the immune function of natural killer cells in liver tissue. Int Immunopharmacol 127:111341","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4340_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1517\/17460441.2010.484460","volume":"5","author":"S Cosconati","year":"2010","unstructured":"Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ (2010) Virtual screening with AutoDock: theory and practice. Expert Opin Drug Discov 5(6):597\u2013607","journal-title":"Expert Opin Drug Discov"},{"issue":"6","key":"4340_CR11","first-page":"1186","volume":"10","author":"IB \u0106ur\u010di\u0107","year":"2022","unstructured":"\u0106ur\u010di\u0107 IB, Kizivat T, Petrovi\u0107 A, Smoli\u0107 R, Tabll A, Wu GY, Smoli\u0107 M (2022) Therapeutic perspectives of IL1 family members in liver diseases: an update. J Clin Transl Hepatol 10(6):1186\u20131193","journal-title":"J Clin Transl Hepatol"},{"issue":"24","key":"4340_CR12","doi-asserted-by":"publisher","first-page":"167309","DOI":"10.1016\/j.jmb.2021.167309","volume":"433","author":"C Dekker","year":"2021","unstructured":"Dekker C, Mattes H, Wright M, Boettcher A, Hinniger A, Hughes N et al (2021) Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition. J Mol Biol 433(24):167309","journal-title":"J Mol Biol"},{"issue":"42","key":"4340_CR13","doi-asserted-by":"publisher","first-page":"39490","DOI":"10.1021\/acsomega.3c05247","volume":"8","author":"AA Elgazar","year":"2023","unstructured":"Elgazar AA, El-Domany RA, Eldehna WM, Badria FA (2023) 3-Acetyl-11-keto-\u03b2-boswellic acid-based hybrids alleviate acetaminophen-induced hepatotoxicity in HepG2 by the regulation of inflammatory and oxidative stress pathways: an integrated approach. ACS Omega 8(42):39490\u201339510","journal-title":"ACS Omega"},{"issue":"17","key":"4340_CR14","doi-asserted-by":"publisher","first-page":"15711","DOI":"10.1021\/acs.jmedchem.4c01341","volume":"67","author":"Z Fu","year":"2024","unstructured":"Fu Z, Duan Y, Pei H, Zou Y, Tang M, Chen Y et al (2024) Discovery of potent, specific, and orally available NLRP3 inflammasome inhibitors based on pyridazine scaffolds for the treatment of septic shock and peritonitis. J Med Chem 67(17):15711\u201315737","journal-title":"J Med Chem"},{"issue":"1","key":"4340_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.trecan.2020.08.005","volume":"7","author":"A Garrido","year":"2021","unstructured":"Garrido A, Djouder N (2021) Cirrhosis: a questioned risk factor for hepatocellular carcinoma. Trends Cancer 7(1):29\u201336","journal-title":"Trends Cancer"},{"issue":"5","key":"4340_CR16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jhep.2018.01.008","volume":"68","author":"N Gehrke","year":"2018","unstructured":"Gehrke N, H\u00f6velmeyer N, Waisman A, Straub BK, Weinmann-Menke J, W\u00f6rns MA et al (2018) Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation. J Hepatol 68(5):986\u2013995","journal-title":"J Hepatol"},{"key":"4340_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-065X.2008.00697.x","volume":"226","author":"KK Hoyer","year":"2008","unstructured":"Hoyer KK, Dooms H, Barron L, Abbas AK (2008) Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 226:19\u201328","journal-title":"Immunol Rev"},{"issue":"2","key":"4340_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/hep.30252","volume":"69","author":"ME Inzaugarat","year":"2019","unstructured":"Inzaugarat ME, Johnson CD, Holtmann TM, McGeough MD, Trautwein C, Papouchado BG et al (2019) NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice. Hepatol 69(2):845\u2013859","journal-title":"Hepatol"},{"issue":"1","key":"4340_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13075-018-1525-z","volume":"20","author":"P Italiani","year":"2018","unstructured":"Italiani P, Manca ML, Angelotti F, Melillo D, Pratesi F, Puxeddu I et al (2018) IL-1 family cytokines and soluble receptors in systemic lupus erythematosus. Arthritis Res Ther 20(1):27","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"4340_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ajg.2017.5","volume":"112","author":"MN Kabbany","year":"2017","unstructured":"Kabbany MN, Selvakumar PKC, Watt K, Lopez R, Akras Z, Zein N et al (2017) Prevalence of nonalcoholic steatohepatitis-associated cirrhosis in the United States: an analysis of national health and nutrition examination survey data. Off J Am Coll Gastroenterology| ACG 112(4):581\u20137","journal-title":"Off J Am Coll Gastroenterology| ACG"},{"issue":"5","key":"4340_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s10753-023-01853-y","volume":"46","author":"RA Kachouei","year":"2023","unstructured":"Kachouei RA, Doagoo A, Jalilzadeh M, Khatami SH, Rajaei S, Jahan-Abad AJ et al (2023) Acetyl-11-keto-beta-boswellic acid has therapeutic benefits for NAFLD rat models that were given a high fructose diet by ameliorating hepatic inflammation and lipid metabolism. Inflamm 46(5):1966\u20131980","journal-title":"Inflamm"},{"issue":"11","key":"4340_CR22","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3945\/jn.109.105858","volume":"139","author":"T Kawasaki","year":"2009","unstructured":"Kawasaki T, Igarashi K, Koeda T, Sugimoto K, Nakagawa K, Hayashi S et al (2009) Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 139(11):2067\u20132071","journal-title":"J Nutr"},{"issue":"1","key":"4340_CR23","doi-asserted-by":"publisher","first-page":"16364","DOI":"10.1038\/s41598-020-73347-y","volume":"10","author":"S Kochumon","year":"2020","unstructured":"Kochumon S, Al Madhoun A, Al-Rashed F, Thomas R, Sindhu S, Al-Ozairi E et al (2020) Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance. Sci Rep 10(1):16364","journal-title":"Sci Rep"},{"issue":"21","key":"4340_CR24","doi-asserted-by":"publisher","first-page":"11700","DOI":"10.1080\/07391102.2022.2163425","volume":"41","author":"H Lanjanian","year":"2023","unstructured":"Lanjanian H, Hosseini S, Narimani Z, Meknatkhah S, Riazi GH (2023) A knowledge-based protein-protein interaction inhibition (KPI) pipeline: an insight from drug repositioning for COVID-19 inhibition. J Biomol Struct Dyn 41(21):11700\u201311713","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"4340_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13046-018-0805-4","volume":"37","author":"W Li","year":"2018","unstructured":"Li W, Liu J, Fu W, Zheng X, Ren L, Liu S et al (2018) 3-O-acetyl-11-keto-\u03b2-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2\/M phase. J Exp Clin Cancer Res 37(1):132","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4340_CR26","first-page":"6108342","volume":"2020","author":"B Li","year":"2020","unstructured":"Li B, Guo Q, Wang Y, Su R, Gao C, Zhao J et al (2020) Increased serum interleukin-2 levels are associated with abnormal peripheral blood natural killer cell levels in patients with active rheumatoid arthritis. Mediators Inflamm 2020(1):6108342","journal-title":"Mediators Inflamm"},{"issue":"5","key":"4340_CR27","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3390\/ijms23052599","volume":"23","author":"JP Lu\u00eds","year":"2022","unstructured":"Lu\u00eds JP, Mata AI, Sim\u00f5es CJV, Brito RMM (2022) Conformational dynamics of the soluble and membrane-bound forms of interleukin-1 receptor type-1: insights into linker flexibility and domain orientation. Int J Mol Sci 23(5):2599","journal-title":"Int J Mol Sci"},{"issue":"16","key":"4340_CR28","first-page":"3422","volume":"14","author":"K Luotola","year":"2022","unstructured":"Luotola K (2022) IL-1 receptor antagonist (IL-1Ra) levels and management of metabolic disorders. Nutr 14(16):3422","journal-title":"Nutr"},{"key":"4340_CR29","doi-asserted-by":"publisher","first-page":"26325","DOI":"10.1038\/srep26325","volume":"6","author":"Y Ma","year":"2016","unstructured":"Ma Y, Gao M, Liu D (2016) Alternating diet as a preventive and therapeutic intervention for high fat diet-induced metabolic disorder. Sci Rep 6:26325","journal-title":"Sci Rep"},{"key":"4340_CR30","doi-asserted-by":"publisher","first-page":"155107","DOI":"10.1016\/j.cyto.2020.155107","volume":"131","author":"N Marefati","year":"2020","unstructured":"Marefati N, Beheshti F, Memarpour S, Bayat R, Naser Shafei M, Sadeghnia HR et al (2020) The effects of acetyl-11-keto-\u03b2-boswellic acid on brain cytokines and memory impairment induced by lipopolysaccharide in rats. Cytokine 131:155107","journal-title":"Cytokine"},{"issue":"21","key":"4340_CR31","doi-asserted-by":"publisher","first-page":"14721","DOI":"10.1021\/acs.jmedchem.2c01250","volume":"65","author":"C McBride","year":"2022","unstructured":"McBride C, Trzoss L, Povero D, Lazic M, Ambrus-Aikelin G, Santini A et al (2022) Overcoming preclinical safety obstacles to discover (S)-N-((1, 2, 3, 5, 6, 7-hexahydro-s-indacen-4-yl) carbamoyl)-6-(methylamino)-6, 7-dihydro-5 H-pyrazolo [5, 1-b][1, 3] oxazine-3-sulfonamide (GDC-2394): a potent and selective NLRP3 inhibitor. J Med Chem 65(21):14721\u201314739","journal-title":"J Med Chem"},{"issue":"4","key":"4340_CR32","first-page":"476","volume":"14","author":"M Meyer","year":"2024","unstructured":"Meyer M, Schw\u00e4rzler J, Jukic A, Tilg H (2024) Innate immunity and MASLD. Biomol 14(4):476","journal-title":"Biomol"},{"issue":"3","key":"4340_CR33","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s10753-020-01190-4","volume":"43","author":"AM Mirea","year":"2020","unstructured":"Mirea AM, Stienstra R, Kanneganti TD, Tack CJ, Chavakis T, Toonen EJM, Joosten LAB (2020) Mice deficient in the IL-1\u03b2 activation genes Prtn3, Elane, and Casp1 are protected against the development of obesity-induced NAFLD. Inflammation 43(3):1054\u20131064","journal-title":"Inflammation"},{"issue":"4","key":"4340_CR34","doi-asserted-by":"publisher","first-page":"2149641","DOI":"10.1002\/eji.202149641","volume":"54","author":"K Mladeni\u0107","year":"2024","unstructured":"Mladeni\u0107 K, Lenarti\u0107 M, Marinovi\u0107 S, Poli\u0107 B, Wensveen FM (2024) The \u201cDomino effect\u201d in MASLD: the inflammatory cascade of steatohepatitis. Eur J Immunol 54(4):2149641","journal-title":"Eur J Immunol"},{"key":"4340_CR35","doi-asserted-by":"publisher","first-page":"672658","DOI":"10.3389\/fmed.2021.672658","volume":"8","author":"HT Nga","year":"2021","unstructured":"Nga HT, Moon JS, Tian J, Lee HY, Kim SH, Lee YS et al (2021) Interleukin-10 attenuates liver fibrosis exacerbated by thermoneutrality. Front Med (Lausanne) 8:672658","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"4340_CR36","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V et al (2012) IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 122(10):3476\u20133489","journal-title":"J Clin Invest"},{"issue":"13","key":"4340_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"issue":"3","key":"4340_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jhep.2011.10.005","volume":"56","author":"J Pihlajam\u00e4ki","year":"2012","unstructured":"Pihlajam\u00e4ki J, Kuulasmaa T, Kaminska D, Simonen M, K\u00e4rj\u00e4 V, Gr\u00f6nlund S et al (2012) Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. J Hepatol 56(3):663\u2013670","journal-title":"J Hepatol"},{"key":"4340_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-4-406","volume":"4","author":"AF Raja","year":"2011","unstructured":"Raja AF, Ali F, Khan IA, Shawl AS, Arora DS (2011) Acetyl-11-keto-\u03b2-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res Notes 4:1\u20138","journal-title":"BMC Res Notes"},{"key":"4340_CR40","doi-asserted-by":"publisher","first-page":"1433857","DOI":"10.3389\/fcell.2024.1433857","volume":"12","author":"R Sandireddy","year":"2024","unstructured":"Sandireddy R, Sakthivel S, Gupta P, Behari J, Tripathi M, Singh BK (2024) Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Front Cell Dev Biol 12:1433857","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"4340_CR41","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.3390\/ijms25084537","volume":"25","author":"K Sayaf","year":"2024","unstructured":"Sayaf K, Battistella S, Russo FP (2024) NLRP3 inflammasome in acute and chronic liver diseases. Int J Mol Sci 25(8):4537","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4340_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaut.2011.01.001","volume":"36","author":"R Sharma","year":"2011","unstructured":"Sharma R, Fu SM, Ju ST (2011) IL-2: a two-faced master regulator of autoimmunity. J Autoimmun 36(2):91\u201397","journal-title":"J Autoimmun"},{"issue":"6","key":"4340_CR43","first-page":"862","volume":"60","author":"H Solleiro-Villavicencio","year":"2024","unstructured":"Solleiro-Villavicencio H, M\u00e9ndez-Garc\u00eda LA, Ocampo-Aguilera NA, Baltazar-P\u00e9rez I, Arreola-Miranda JA, Aguayo-Guerrero JA et al (2024) Decreased hepatic and serum levels of IL-10 concur with increased lobular inflammation in morbidly obese patients. Med 60(6):862","journal-title":"Med"},{"issue":"4","key":"4340_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1089\/wound.2019.1032","volume":"9","author":"EH Steen","year":"2020","unstructured":"Steen EH, Wang X, Balaji S, Butte MJ, Bollyky PL, Keswani SG (2020) The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis. Adv Wound Care (New Rochelle) 9(4):184\u2013198","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"4340_CR45","doi-asserted-by":"publisher","first-page":"2620710","DOI":"10.1155\/2022\/2620710","volume":"2022","author":"D Taherzadeh","year":"2022","unstructured":"Taherzadeh D, Baradaran Rahimi V, Amiri H, Ehtiati S, Yahyazadeh R, Hashemy SI, Askari VR (2022) Acetyl-11-keto-\u03b2-boswellic acid (AKBA) prevents lipopolysaccharide-induced inflammation and cytotoxicity on H9C2 cells. Evid Based Complement Alternat Med 2022:2620710","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"4340_CR46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","volume":"23","author":"S Tahtinen","year":"2022","unstructured":"Tahtinen S, Tong A-J, Himmels P, Oh J, Paler-Martinez A, Kim L et al (2022) IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat Immunol 23(4):532\u2013542","journal-title":"Nat Immunol"},{"issue":"2","key":"4340_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"8","key":"4340_CR48","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/genes13081324","volume":"13","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A et al (2022) Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes (Basel) 13(8):1324","journal-title":"Genes (Basel)"},{"issue":"1","key":"4340_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/imammb\/dqw021","volume":"35","author":"RS Waters","year":"2018","unstructured":"Waters RS, Perry JSA, Han S, Bielekova B, Gedeon T (2018) The effects of interleukin-2 on immune response regulation. Math Med Biol 35(1):79\u2013119","journal-title":"Math Med Biol"},{"key":"4340_CR50","doi-asserted-by":"publisher","first-page":"780496","DOI":"10.3389\/fphar.2022.780496","volume":"13","author":"L Yu","year":"2022","unstructured":"Yu L, Hong W, Lu S, Li Y, Guan Y, Weng X, Feng Z (2022) The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment. Front Pharmacol 13:780496","journal-title":"Front Pharmacol"},{"issue":"2","key":"4340_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4254\/wjh.v15.i2.180","volume":"15","author":"CY Zhang","year":"2023","unstructured":"Zhang CY, Liu S, Yang M (2023) Antioxidant and anti-inflammatory agents in chronic liver diseases: molecular mechanisms and therapy. World J Hepatol 15(2):180\u2013200","journal-title":"World J Hepatol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04340-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04340-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04340-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:01:58Z","timestamp":1764824518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04340-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4340"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04340-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the ethics committee at Shahid Beheshti University of medical sciences (Ethical Code: IR.SBMU.MSP.REC.1399.308) and were conducted in accordance with Animal Care Committee guidelines of the Shahid Beheshti University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}